Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB

GLIA

Volumn 62, Issue 4, 2014, Pages 580-591

  Rusielewicz, Tomasz ^a,b   Nam, Jennifer ^a   Damanakis, Evangelos ^a   John, Gareth R ^c   Raine, Cedric S ^d   Melendez Vasquez, Carmen V ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cytoskeleton; Myosin II; Oligodendrocytes; Remyelination

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; MYELIN BASIC PROTEIN; MYOSIN IIB; NON MUSCLE MYOSIN II; PROTEOLIPID PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; COCULTURE; COMPARATIVE STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DEMYELINATION; FEMALE; GLIAL CELL CULTURE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; MYELINATED NERVE; NERVE FIBER; NERVE REGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; SPINAL CORD; WILD TYPE;

CYTOSKELETON; MYOSIN II; OLIGODENDROCYTES; REMYELINATION;

ANIMALS; ANTIGENS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CORPUS CALLOSUM; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUMINESCENT PROTEINS; LYSOPHOSPHATIDYLCHOLINES; MICE; MICE, TRANSGENIC; MYELIN BASIC PROTEIN; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; NERVE REGENERATION; NERVE TISSUE PROTEINS; NONMUSCLE MYOSIN TYPE IIB; OLIGODENDROGLIA; PROTEOGLYCANS;

EID: 84893816749     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22627     Document Type: Article

References (48)

1. Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR. 2006. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 177:5574-5584.
2. Bauer NG, Richter-Landsberg C, Ffrench-Constant C. 2009. Role of the oligodendroglial cytoskeleton in differentiation and myelination. Glia 57:1691-1705.
3. Bruce CC, Zhao C, Franklin RJ. 2010. Remyelination-An effective means of neuroprotection. Horm Behav 57:56-62.
4. Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD. 2012. Cortical remyelination: A new target for repair therapies in multiple sclerosis. Ann Neurol 72:918-926.
5. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
6. Chong SY, Rosenberg SS, Fancy SP, Zhao C, Shen YA, Hahn AT, McGee AW, Xu X, Zheng B, Zhang LI, Rowitch DH, Franklin RJ, Lu QR, Chan JR. 2012. Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination. Proc Natl Acad Sci USA 109:1299-1304.
7. Crang AJ, Gilson J, Blakemore WF. 1998. The demonstration by transplantation of the very restricted remyelinating potential of post-mitotic oligodendrocytes. J Neurocytol 27:541-553.
8. Doerflinger NH, Macklin WB, Popko B. 2003. Inducible site-specific recombination in myelinating cells. Genesis 35:63-72.
9. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. 2006. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26:10967-10983.
10. Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH. 2011. Myelin regeneration: A recapitulation of development? Annu Rev Neurosci 34:21-43.
11. Fields RD, Ellisman MH. 1986. Axons regenerated through silicone tube splices. II. Functional morphology. Exp Neurol 92:61-74.
12. Forrest AD, Beggs HE, Reichardt LF, Dupree JL, Colello RJ, Fuss B. 2009. Focal adhesion kinase (FAK): A regulator of CNS myelination. J Neurosci Res 87:3456-3464.
13. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
14. Frohman EM, Racke MK, Raine CS. 2006. Multiple sclerosis-The plaque and its pathogenesis. N Engl J Med 354:942-955.
15. Gensert JM, Goldman JE. 2001. Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. J Neurobiol 48:75-86.
16. Hou SW, Liu CY, Li YH, Yu JZ, Feng L, Liu YT, Guo MF, Xie Y, Meng J, Zhang HF, Xiao BG, Ma CG. 2012. Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect. CNS Neurosci Ther 18:909-917.
17. Huang XN, Fu J, Wang WZ. 2011. The effects of fasudil on the permeability of the rat blood-brain barrier and blood-spinal cord barrier following experimental autoimmune encephalomyelitis. J Neuroimmunol 239:61-67.
18. Kim HJ, DiBernardo AB, Sloane JA, Rasband MN, Solomon D, Kosaras B, Kwak SP, Vartanian TK. 2006. WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. J Neurosci 26:5849-5859.
19. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248.
20. Kippert A, Trajkovic K, Rajendran L, Ries J, Simons M. 2007. Rho regulates membrane transport in the endocytic pathway to control plasma membrane specialization in oligodendroglial cells. J Neurosci 27:3560-3570.
21. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267-276.
22. Kucharova K, Chang Y, Boor A, Yong VW, Stallcup WB. 2011. Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord. J Neuroinflammation 8:158.
23. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, Metzger D, Macklin WB, Chambon P, Suter U. 2003. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci 22:430-440.
24. Levine JM, Reynolds R, Fawcett JW. 2001. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24:39-47.
25. Ludwin SK. 1979. The perineuronal satellite oligodendrocyte. A role in remyelination. Acta Neuropathol 47:49-53.
26. Ma X, Takeda K, Singh A, Yu ZX, Zerfas P, Blount A, Liu C, Towbin JA, Schneider MD, Adelstein RS, Wei Q. 2009. Conditional ablation of nonmuscle myosin II-B delineates heart defects in adult mice. Circ Res 105:1102-1109.
27. Mallon BS, Shick HE, Kidd GJ, Macklin WB. 2002. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22:876-885.
28. Merkler D, Ernsting T, Kerschensteiner M, Bruck W, Stadelmann C. 2006. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 129(Pt 8):1972-1983.
29. Moll NM, Hong E, Fauveau M, Naruse M, Kerninon C, Tepavcevic V, Klopstein A, Seilhean D, Chew LJ, Gallo V, Oumesmar BN. 2013. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis. Glia 61:1659-1672.
30. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. 2007. A global double-fluorescent Cre reporter mouse. Genesis 45:593-605.
31. Nait-Oumesmar B, Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, Baron-Van Evercooren A. 1999. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci 11:4357-4366.
32. Nave KA. 2010. Myelination and support of axonal integrity by glia. Nature 468:244-252.
33. Nielsen HH, Ladeby R, Drojdahl N, Peterson AC, Finsen B. 2006. Axonal degeneration stimulates the formation of NG2+ cells and oligodendrocytes in the mouse. Glia 54:105-115.
34. Pillai AM, Thaxton C, Pribisko AL, Cheng JG, Dupree JL, Bhat MA. 2009. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains. J Neurosci Res 87:1773-1793.
35. Pluchino S, Muzio L, Imitola J, Deleidi M, Alfaro-Cervello C, Salani G, Porcheri C, Brambilla E, Cavasinni F, Bergamaschi A, Garcia-Verdugo JM, Comi G, Khoury SJ, Martino G. 2008. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 131(Pt 10):2564-2578.
36. Raine CS, Cross AH. 1989. Axonal dystrophy as a consequence of long-term demyelination. Lab Invest 60:714-725.
37. Raine CS, Scheinberg L, Waltz JM. 1981. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 45:534-546.
38. Salzer JL. 2003. Polarized domains of myelinated axons. Neuron 40:297-318.
39. Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, Voss E, Berger K, Kipp M, Baumgartner W, Stangel M. 2013. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136:147-167.
40. Sloane JA, Vartanian TK. 2007. Myosin Va controls oligodendrocyte morphogenesis and myelination. J Neurosci 27:11366-11375.
41. Trapp BD, Nishiyama A, Cheng D, Macklin W. 1997. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137:459-468.
42. Wang H, Rusielewicz T, Tewari A, Leitman EM, Einhenber S, Melendez-Vasquez CV. 2012. Myosin II is a negative regulator of oligodendrocyte morphological differentiation. J Neurosci Res 90:1547-1556.
43. Wang H, Tewari A, Einheber S, Salzer JL, Melendez-Vasquez CV. 2008. Myosin II has distinct functions in PNS and CNS myelin sheath formation. J Cell Biol 182:1171-1184.
44. Watanabe M, Toyama Y, Nishiyama A. 2002. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 69:826-836.
45. Wolswijk G. 2000. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain : a journal of neurology 123 (Pt 1):105-115.
46. Woodruff RH, Franklin RJ. 1999. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25:216-228.
47. Yu JZ, Ding J, Ma CG, Sun CH, Sun YF, Lu CZ, Xiao BG. 2010. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor. J Neurosci Res 88:1664-1672.
48. Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, Lu QR, Rowitch DH, Raine CS, Brosnan CF, John GR. 2009. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci USA 106:19162-19167.